Dr. Leff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
178 Seminary Dr
Menlo Park, CA 94025Phone+1 650-521-0353- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1990
- University of ColoradoResidency, Internal Medicine, 1984 - 1987
- Perelman School of Medicine at the University of PennsylvaniaClass of 1984
Certifications & Licensure
- CA State Medical License 2003 - 2024
- NJ State Medical License 1994 - 2003
- CO State Medical License 1985 - 2001
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency.Höybye, C., Pfeiffer, A. F., Ferone, D., Christiansen, J. S., Gilfoyle, D., Christoffersen, E. D., Mortensen, E., Leff, J. A., Beckert, M.> ;Endocrine connections. 2017 Feb 16
- 298 citationsPirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lis...> ;The European Respiratory Journal. 2016 Jan 1
- 82 citationsComprehensive assessment of the long‐term safety of pirfenidone in patients with idiopathic pulmonary fibrosisDominique Valeyre, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Talmadge E. King, Jonathan A. Leff, Paul W. Noble, Steven A. Sahn, Roland M. du Bois> ;Respirology. 2014 Jul 1
- Join now to see all
Press Mentions
- Up and down the Ladder: The Latest Comings and GoingsFebruary 26th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: